Device Consumable Dentistry

Aquasil Ultra+ Digit Smart Wetting Impression Material

Payments companies reported to CMS as associated with Aquasil Ultra+ Digit Smart Wetting Impression Material. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$18Kassociated payments (2023-2025)
329clinicians with associated payments
2companies reporting

By year

2023 $4,865
2024 $4,673
2025 $8,602

Payments reported as associated with Aquasil Ultra+ Digit Smart Wetting Impression Material, per program year, as reported to CMS.

Who makes it

Specialties most often involved

General Practice (Dentist) $13K
Dentist $3,892
Periodontics $276
Prosthodontics $85.89
Oral and Maxillofacial Surgery $80.97
Pediatric Dentistry $66.73

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Aquasil Ultra+ Digit Smart Wetting Impression Material

These are the largest totals companies reported as associated with Aquasil Ultra+ Digit Smart Wetting Impression Material. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Andrew Hall Colorado Springs, CO General Practice (Dentist) $7,380.00
Alan Boghosian Chicago, IL General Practice (Dentist) $1,061.55
Christopher Bauer Fresno, CA Dentist $163.48
Lori Trost Red Bud, IL Dentist $154.07
Hemant Sachdeva San Diego, CA General Practice (Dentist) $138.44
Richard Hada Fallbrook, CA General Practice (Dentist) $138.44
Matthew Kanter Murrieta, CA Dentist $138.44
Nathan Christenson La Mesa, CA General Practice (Dentist) $138.44
Jeffrey Papworth Murrieta, CA Dentist $138.43
Raquel Reyes San Diego, CA General Practice (Dentist) $138.43

Prescribed Aquasil Ultra+ Digit Smart Wetting Impression Material?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.